Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06520774 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 2 to 17v5
  2. Study sites: 3 to 2v4
  3. Study sites: 2 to 3v3
  4. Trial status: Not Yet Recruiting to Recruitingv2 Show 7 more changesShow less
    • Primary endpoints: 1 to 2
    • Study sites: 0 to 2
    • Primary completion date: Oct 1, 2027 to Jul 30, 2027
    • Study completion date: Oct 30, 2031 to Jun 30, 2031
    • Start date changed from estimate of Sep 1, 2024 to May 30, 2024
    • Eligibility criteria shortened, about 24 words
    • Secondary endpoints revised (13)
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of the study is to evaluate the safety and efficacy of the Lifetech Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases
Trial Details
NCT Number NCT06520774
Lead Sponsor Lifetech Scientific (Shenzhen) Co., Ltd.
Collaborators: Second Xiangya Hospital of Central South University
Conditions
(from sponsor)		 Aortic Arch Aneurysm, Penetrating Aortic Ulcer
Related terms Aneurysm, Aortic Arch, Penetrating Atherosclerotic Ulcer
Enrollment 103 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov